维普中文期刊产品整合服务
10篇 您的检索式:作者名="Bisgin A"
    题名 作者 年代 出处 被引量
1NF-kB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL 显示文摘Aydin C Sanlioglu A D Bisgin A 2010BMC Cancer2010,10,:1
2IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-lgE treatment显示文摘Yalcin AD Bisgin A Gorczynski RM 2012Mediators Inflamm2012,,72:1
3IL-8, IL-10, TGF- ,and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment 显示文摘Yalcin AD Bisgin A Gorczynski RM 2012Mediators of Inflammation2012,1,2012:1
4Level of TNF - related apopto-sis -inducing - ligand and CXCL8 correlated with 2 - Fluo-ro - 2 - deoxy - D - glucose uptake in anti - VEGF treated coloncancers显示文摘Celik B Yalcin AD Bisgin A 2013Med Sci Monit2013,19,:1
5Trimetazidine effect on burn- induced intestinal mucosal injury and kidney damage in rats显示文摘Yalcin AD Bisgin A Erbay RH 2012Int J Bums Trauma2012,2,2:1
6Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment显示文摘Yalcin AD Bisgin A Kargi A 2012Med Sci Monit2012,18,3:1
7Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non- drug using diabetic patients显示文摘Bisgin A Yalcin AD Gorczynski RM 2012Diabetes Res Clin Pract2012,96,3:1
8Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis显示文摘Terzioglu E Bisgin A Sanlioglu AD et at 2007Rheumatology2007,46,5:1
9NF-KB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL 显示文摘Aydin C Sanlioglu AD Bisgin A 2010BMC Cancer2010,10,:1
10Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer显示文摘Bisgin A Kargi A Yalcin AD 2012BMC Cancer2012,12,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费